The Impact of Olive Oil Polyphenol Supplementation on Metabolic Syndrome Parameters: Preclinical Investigations Have Demonstrated That Olive Oil Polyphenols, Notably Oleocanthal, Oleacein, and Allied Secoiridoids, Possess Anti-inflammatory and Antioxidant Attributes
NCT07144488 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 106
Last updated 2025-08-27
Summary
Olive oil polyphenols, particularly oleocanthal, oleacein, and related secoiridoids, have shown anti-inflammatory and antioxidant properties in preclinical studies. Metabolic syndrome (MetS) is characterized by a constellation of risk factors, including central obesity, dyslipidemia, hypertension, and dysglycemia, which collectively contribute to a substantially elevated risk of cardiovascular disease (CVD) and type 2 diabetes mellitus (T2DM). Preclinical investigations have demonstrated that olive oil polyphenols, notably oleocanthal, oleacein, and allied secoiridoids, possess anti-inflammatory and antioxidant attributes.
The goal of this clinical trial is to learn if a polyphenol-rich olive oil extract works to improve metabolic syndrome (MetS) parameters in adults. It will also evaluate the safety of the supplement. The main questions it aims to answer are:
Does the olive oil extract improve fasting blood glucose and HbA1c levels?
How does the supplement affect other health measures such as cholesterol levels, inflammation (CRP), body mass index (BMI), blood pressure, waist size, liver function (ALT), kidney function (eGFR), uric acid levels, and fatigue?
Researchers will compare the olive oil extract supplement to a placebo (a look-alike substance with no active ingredients) to see if the supplement can help manage metabolic syndrome.
Participants will:
Take either 10 mg of the olive oil extract supplement or a placebo once daily for 12 weeks
Attend clinic visits for tests and checkups at the beginning and end of the study period
Have their blood sugar, cholesterol, inflammation markers, liver and kidney function, and other health parameters measured before and after the treatment
Complete questionnaires assessing fatigue levels
Conditions
- Metabolic Syndrome
Interventions
- DIETARY_SUPPLEMENT
-
Olive Oil Polyphenol Supplement (OOPs, OLEOPROTECT®, Thousand Olives®)
Participants receive two capsules daily (total 10 mg/day) of a standardized olive oil polyphenol extract. Each capsule contains 5 mg of aldehydic phenols: 75% oleocanthal/oleacein and 25% oleuropein aglycon/ligstroside aglycon. Formulated with PEG400, cellulose, silicon dioxide, and magnesium stearate. Duration: 12 weeks.
- DIETARY_SUPPLEMENT
-
Placebo capsules
Two capsules taken daily for 12 weeks. Identical in weight, appearance, and taste to the active OOPs capsules. Contain PEG400, cellulose, silicon dioxide, and magnesium stearate, but no active olive oil polyphenols.
Sponsors & Collaborators
-
University of Nicosia
collaborator OTHER -
University of Crete
collaborator OTHER -
National and Kapodistrian University of Athens
collaborator OTHER -
Yale University
collaborator OTHER -
Apostolos Loukas Medical Centre Cyprus
lead NETWORK
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 30 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-09-01
- Primary Completion
- 2025-01-01
- Completion
- 2025-01-01
Countries
- Cyprus
Study Locations
More Related Trials
-
The Effects of Omega-3 Fatty Acids on Metabolic Syndrome
NCT00350194 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Effects of Omega-3 Fatty Acids on Markers of Inflammation
NCT01129050 ·Status: COMPLETED ·Phase: NA
-
Nutritional Oleic Acid Modulation of adIpose Cholesterol Metabolism in Patients Living With Obesity
NCT07027033 ·Status: RECRUITING ·Phase: NA
-
Efficacy of Fish Oil or Olive Oil Supplementation on the Health Effects of Ozone Exposure in Healthy Young Subjects
NCT03395119 ·Status: COMPLETED ·Phase: PHASE1
-
Metabolic Actions of Omega-3 Fatty Acids
NCT01896414 ·Status: COMPLETED ·Phase: NA
-
Does Consuming Modified Plant Seed Oil Containing Fish Oil Fatty Acids Act in the Same Way as Consuming Fish Oil?
NCT03477045 ·Status: COMPLETED ·Phase: NA
-
Effects of Dietary Fatty Acids on Octadecanoid Production and Biological Actions in Obesity-induced Inflammation
NCT03583281 ·Status: COMPLETED ·Phase: NA
-
Metabolic Effects of Linoleic Acid-Rich Oil Compared to a Blend Oil in Adults With Insulin Resistance
NCT07287514 ·Status: RECRUITING ·Phase: NA
-
Study of Metabolic Syndrome Use Omega-3 Fatty Acids and Low Fat Meal
NCT01768169 ·Status: UNKNOWN
-
A Study to Evaluate the Effects of a Marine Lipid Oil Concentrate Formulation on Inflammation
NCT04269876 ·Status: TERMINATED ·Phase: NA
-
CCRC: Understanding the Effects of Omega-3 Fatty Acids Versus Lignans in Flaxseed on Metabolic and Inflammatory Markers Leading to Diabetes and Cardiovascular Disease
NCT00935922 ·Status: COMPLETED ·Phase: NA
-
Monounsaturated Fatty Acid Supplementation for Overweight and Obese Individuals With Prediabetes
NCT05560971 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effect of Omega-3 PUFA Supplementation in NAFLD Patients
NCT00230113 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Omega 3 Fatty Acids on Vascular Function
NCT01888211 ·Status: COMPLETED ·Phase: NA
-
Alpha-Linolenic Acid and Inflammatory Markers
NCT00967733 ·Status: COMPLETED ·Phase: NA
-
Investigating the Effect of 4-week Omega-3 Polyunsaturated Fatty Acid Supplementation on Inflammation
NCT03210805 ·Status: UNKNOWN ·Phase: NA
-
Effect of Bioactive Enriched Food on Markers of Metabolic Syndrome
NCT03956433 ·Status: COMPLETED ·Phase: NA
-
Effect of Omega -3 Fatty Acids Supplements and Plant Sterol Enriched Food in Dyslipidemic Adults
NCT00422266 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Dietary Polyphenols and ω-3 Fatty Acids on Cardiovascular Risk Factors in High Risk Subjects
NCT01154478 ·Status: COMPLETED ·Phase: NA
-
Oxidized Omega-3 Supplements With Different Oxidation
NCT01799720 ·Status: COMPLETED ·Phase: NA
-
Efficacy Study Regarding the Beneficial Effects of Omega-3 Fatty Acids on Cardiometabolic Health
NCT02042274 ·Status: COMPLETED ·Phase: NA
-
Evaluation of MF4637 for Correcting the Omega-3 Nutritional Deficiency in NAFLD Patients
NCT02923804 ·Status: COMPLETED ·Phase: NA
-
Polyunsaturated Fatty Acids Supplementation and Blood Metabolome
NCT03892486 ·Status: UNKNOWN ·Phase: NA
-
Differential Effects of Eicosapentaenoic Acid (EPA) and Docosahexaenoic Acid (DHA) on Platelet, Endothelial and Vascular Function
NCT01735357 ·Status: COMPLETED ·Phase: NA
-
Intake of Omega 3 in Morbidly Obese Patients
NCT02113696 ·Status: COMPLETED ·Phase: NA